Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2004 3
2005 1
2006 5
2008 3
2009 2
2010 7
2011 15
2012 16
2013 11
2014 31
2015 35
2016 53
2017 53
2018 46
2019 47
2020 60
2021 65
2022 60
2023 58
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

588 results

Results by year

Filters applied: . Clear all
Page 1
Addressing cancer's grand challenges.
Mullard A. Mullard A. Nat Rev Drug Discov. 2020 Dec;19(12):825-826. doi: 10.1038/d41573-020-00202-0. Nat Rev Drug Discov. 2020. PMID: 33173229 No abstract available.
FDA approves 100th monoclonal antibody product.
Mullard A. Mullard A. Nat Rev Drug Discov. 2021 Jul;20(7):491-495. doi: 10.1038/d41573-021-00079-7. Nat Rev Drug Discov. 2021. PMID: 33953368 No abstract available.
Emer Cooke.
Mullard A. Mullard A. Nat Rev Drug Discov. 2021 Jan;20(1):12-13. doi: 10.1038/d41573-020-00218-6. Nat Rev Drug Discov. 2021. PMID: 33311579 No abstract available.
Aviv Regev.
Mullard A. Mullard A. Nat Rev Drug Discov. 2021 Apr;20(4):256-257. doi: 10.1038/d41573-021-00051-5. Nat Rev Drug Discov. 2021. PMID: 33731922 No abstract available.
Kathy High.
Mullard A. Mullard A. Nat Rev Drug Discov. 2021 Mar;20(3):170-171. doi: 10.1038/d41573-021-00033-7. Nat Rev Drug Discov. 2021. PMID: 33603156 No abstract available.
2021 FDA approvals.
Mullard A. Mullard A. Nat Rev Drug Discov. 2022 Feb;21(2):83-88. doi: 10.1038/d41573-022-00001-9. Nat Rev Drug Discov. 2022. PMID: 34983958 No abstract available.
R&D re-balancing act.
Mullard A. Mullard A. Nat Rev Drug Discov. 2023 Apr;22(4):258. doi: 10.1038/d41573-023-00042-8. Nat Rev Drug Discov. 2023. PMID: 36890217 No abstract available.
Setting GPCRs free.
Mullard A. Mullard A. Nat Rev Drug Discov. 2023 May;22(5):347-348. doi: 10.1038/d41573-023-00064-2. Nat Rev Drug Discov. 2023. PMID: 37069282 No abstract available.
2022 FDA approvals.
Mullard A. Mullard A. Nat Rev Drug Discov. 2023 Feb;22(2):83-88. doi: 10.1038/d41573-023-00001-3. Nat Rev Drug Discov. 2023. PMID: 36596858 No abstract available.
Carolyn Bertozzi.
Mullard A. Mullard A. Nat Rev Drug Discov. 2020 Dec;19(12):830-831. doi: 10.1038/d41573-020-00200-2. Nat Rev Drug Discov. 2020. PMID: 33159188 No abstract available.
588 results